- Home
- APLT vs AMAL Comparison
APLT vs AMAL Comparison
Compare APLT & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AMAL
- Stock Information
- Founded
- APLT 2016
- AMAL 1923
- Country
- APLT United States
- AMAL United States
- Employees
- APLT N/A
- AMAL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- APLT Health Care
- AMAL Finance
- Exchange
- APLT Nasdaq
- AMAL Nasdaq
- Market Cap
- APLT 44.0M
- AMAL 937.6M
- IPO Year
- APLT 2019
- AMAL 2018
- Fundamental
- Price
- APLT $0.41
- AMAL $32.94
- Analyst Decision
- APLT Buy
- AMAL Buy
- Analyst Count
- APLT 7
- AMAL 2
- Target Price
- APLT $6.10
- AMAL $38.50
- AVG Volume (30 Days)
- APLT 2.6M
- AMAL 197.0K
- Earning Date
- APLT 08-06-2025
- AMAL 07-24-2025
- Dividend Yield
- APLT N/A
- AMAL 1.68%
- EPS Growth
- APLT N/A
- AMAL 9.81
- EPS
- APLT N/A
- AMAL 3.36
- Revenue
- APLT $265,000.00
- AMAL $303,970,000.00
- Revenue This Year
- APLT $1,768.13
- AMAL $11.72
- Revenue Next Year
- APLT $292.85
- AMAL $12.48
- P/E Ratio
- APLT N/A
- AMAL $9.92
- Revenue Growth
- APLT N/A
- AMAL 7.13
- 52 Week Low
- APLT $0.30
- AMAL $25.03
- 52 Week High
- APLT $10.62
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- APLT 58.87
- AMAL 63.07
- Support Level
- APLT $0.32
- AMAL $32.82
- Resistance Level
- APLT $0.36
- AMAL $33.58
- Average True Range (ATR)
- APLT 0.04
- AMAL 0.69
- MACD
- APLT 0.01
- AMAL 0.15
- Stochastic Oscillator
- APLT 94.92
- AMAL 81.70
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.